Online inquiry

IVTScrip™ mRNA-Human ALG12, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK16612MR)

This product GTTS-WK16612MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 0 & N1-Methylpseudo-UTP. It ecodes the ALG12 protein. This product can be used in Natural killer T (NKT) cell-related researches.
Specifications
Product type mRNA
Modified bases N1-Methylpseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_024105.4
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 79087
UniProt ID Q9BV10
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ALG12, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) (GTTS-WK16612MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK3901MR IVTScrip™ mRNA-Human Intestinal Alkaline Phosphatase, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA Intestinal Alkaline Phosphatase
GTTS-WK12434MR IVTScrip™ mRNA-Human ACOT2, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ACOT2
GTTS-WK26958MR IVTScrip™ mRNA-Human ATG3, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ATG3
GTTS-WK17861MR IVTScrip™ mRNA-Human AMT, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA AMT
GTTS-WK24730MR IVTScrip™ mRNA-Human ARIH2, (Cap 0, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ARIH2
GTTS-WK19367MR IVTScrip™ mRNA-Human ANAPC1, (Cap 1, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ANAPC1
GTTS-WK20259MR IVTScrip™ mRNA-Human AMPD3, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA AMPD3
GTTS-WK19030MR IVTScrip™ mRNA-Human ALOX12P2, (Cap 1, 2-Thio-UTP, 120 nt-poly(A)) mRNA ALOX12P2
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW